EDGAR Filing Documents for 0001193125-11-156941

Form 8-K - Current report:

SEC Accession No. 0001193125-11-156941

Filing Date

2011-06-02

Accepted

2011-06-02 12:20:54

Documents

Period of Report

2011-05-26

Items

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d8k.htm	8-K	41535
2	CERTIFICATE OF AMENDMENT TO ARTICLES OF INCORPORATION OF PRO-PHARMACEUTICALS	dex31.htm	EX-3.1	5761
3	CERTIFICATE OF AMENDMENT TO ARTICLES OF INCORPORATION OF PRO-PHARMACEUTICALS	dex32.htm	EX-3.2	5219
4	CERTIFICATE OF AMENDMENT TO ARTICLES OF INCORPORATION OF PRO-PHARMACEUTICALS	dex33.htm	EX-3.3	7388
5	EMPLOYMENT AGREEMENT	dex101.htm	EX-10.1	95842
6	PRESS RELEASE	dex991.htm	EX-99.1	15120
7	PRESS RELEASE	dex992.htm	EX-99.2	11653
8	GRAPHIC	g192154ex991_pg001.jpg	GRAPHIC	5065
9	GRAPHIC	g192154ex992_pg001.jpg	GRAPHIC	5065
	Complete submission text file	0001193125-11-156941.txt		198305

Mailing Address 189 WELLS ST STE 200 NEWTON MA 02459

Business Address 189 WELLS ST STE 200 NEWTON MA 02459 617-559-0033

GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)